#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	23280	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2240	1025.8	0	.	n	.	0	C451T	SNP	451	451	C	694	694	T	1287	T,C	682,557	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	23280	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2240	1025.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1427	1427	C	1335	C,G	1282,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	23280	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2240	1025.8	0	HET	.	.	.	C207T,G	.	207	207	C	450	450	C	1282	C,T,G	972,251,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	43032	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3476	1225.0	0	.	n	.	0	T695C	SNP	695	695	T	1043	1043	C	1361	C	1313	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	43032	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3476	1225.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2319	2319	C	1354	C	1286	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	43032	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3476	1225.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2393	2393	A	1332	A	1292	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	43032	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3476	1225.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	2945	2945	C	1290	C,T	1258,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	43032	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3476	1225.0	0	HET	.	.	.	A1638G,T	.	1638	1638	A	1986	1986	A	1325	A,G,T	695,578,1	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	2832	folP	855	855	100.0	folP.l15.c30.ctg.1	1401	199.0	1	SNP	p	R229S	1	.	.	685	687	AGC	938	940	AGC	284;287;288	A;G;C	273;277;278	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	7504	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3412	217.7	1	SNP	p	S91F	1	.	.	271	273	TTC	609	611	TTC	247;244;246	T;T;C	235;236;236	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	7504	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3412	217.7	1	SNP	p	G95N	0	.	.	283	285	GGC	621	623	GGC	236;235;234	G;G;C	228;229;228	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	7504	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3412	217.7	1	SNP	p	D95G	1	.	.	283	285	GGC	621	623	GGC	236;235;234	G;G;C	228;229;228	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	2356	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1312	177.8	1	SNP	p	G45D	0	.	.	133	135	GGC	465	467	GGC	293;290;290	G;G;C,T	287;282;285,1	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1270	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	987	127.5	0	.	n	.	0	A197.	DEL	197	197	A	603	603	A	299	A	286	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6854	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2815	240.9	1	SNP	p	D86N	0	.	.	256	258	GAC	487	489	GAC	236;235;234	G;A,G;C	233;228,1;232	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6854	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2815	240.9	1	SNP	p	R87I	0	.	.	259	261	CGT	490	492	CGT	231;229;229	C;G;T	229;226;221	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6854	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2815	240.9	1	SNP	p	S87R	1	.	.	259	261	CGT	490	492	CGT	231;229;229	C;G;T	229;226;221	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6854	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2815	240.9	1	SNP	p	R87W	0	.	.	259	261	CGT	490	492	CGT	231;229;229	C;G;T	229;226;221	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6854	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2815	240.9	1	SNP	p	S88P	0	.	.	262	264	TCC	493	495	TCC	229;230;232	T;C;C	225;227;230	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	6098	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2643	228.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1561	1563	GGC	279;273;272	G;G;C	269;263;259	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	6490	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2360	271.5	1	SNP	p	A311V	0	.	.	931	933	GCC	1262	1264	GCC	347;348;350	G,A;C,G;C	333,1;336,1;339	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	6490	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2360	271.5	1	SNP	p	I312M	1	.	.	934	936	ATG	1265	1267	ATG	352;352;352	A;T;G	343;343;340	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	6490	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2360	271.5	1	SNP	p	V316T	1	.	.	946	948	ACC	1277	1279	ACC	356;356;356	A;C;C	336;345;345	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	6490	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2360	271.5	1	SNP	p	T316P	0	.	.	946	948	ACC	1277	1279	ACC	356;356;356	A;C;C	336;345;345	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	6490	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2360	271.5	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1778	1780	ACC	343;343;349	A;C,T;C	326;331,1;339	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	6490	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2360	271.5	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1832	1834	GCG	338;339;336	G;C;G	324;325;319	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	6490	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2360	271.5	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1832	1834	GCG	338;339;336	G;C;G	324;325;319	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	6490	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2360	271.5	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1955	1957	GGT	266;265;262	G;G;T	255;253;244	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	6490	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2360	271.5	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1964	1966	AGC	248;248;245	A;G;C	236;239;233	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	6490	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2360	271.5	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1982	1984	CCG	203;207;204	C,G;C;G	182,3;189;176	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	8540	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3227	262.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1638	1640	CCG	286;287;285	C,T;C;G,C	265,1;270;261,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	3178	porA	1146	1146	99.91	porA.l6.c17.ctg.1	1696	183.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	448	448	C	210	C	195	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	4504	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1652	268.8	1	SNP	p	G120K	1	.	.	358	360	AAG	766	768	AAG	359;362;364	A;A;G	344;350;340	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	4504	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1652	268.8	1	SNP	p	N121D	0	.	.	361	363	AAC	769	771	AAC	365;364;361	A,G,C;A;C	340,1,1;349;340	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	4504	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1652	268.8	1	SNP	p	A121N	1	.	.	361	363	AAC	769	771	AAC	365;364;361	A,G,C;A;C	340,1,1;349;340	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	16560	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4756	344.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1818	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1112	161.7	1	SNP	p	V57M	1	.	.	169	171	ATG	582	584	ATG	376;377;373	A;T;G	366;368;361	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
